Search results

68 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Protein in the brain can 'put the brakes' on binge drinking
A new study led by UNC researchers identifies both where in the brain and how a protein in the brain, called Neuropeptide Y or NPY, can act to suppress binge alcohol drinking. These findings suggest that restoring NPY may be useful for treating alcohol use disorders and may also protect some individuals from becoming alcohol dependent.
Located in News / 2015 / March
UNC researchers awarded pilot grants for Zika research
UNC investigators will study diagnostics, transmission, and neurological effects of Zika, which has been reported in 62 countries and territories.
Located in News / 2016 / June
UNC researchers develop innovative gene transfer-based treatment approach
The experimental treatment uses a genetically modified virus to deliver a missing gene into the cerebrospinal fluid of children with giant axonal neuropathy (GAN).
Located in News / 2015 / June
P Rex-1 protein key to melanoma metastasis
Researchers from UNC Lineberger Comprehensive Cancer Center are part of a team that has identified a protein, called P-Rex1, that is key to the movement of cells called melanoblasts. When these cells experience uncontrolled growth, melanoma develops.
Located in News / 2011 / November
UNC scientists find potential cause for deadly breast cancer relapse
Adriana S. Beltran, PhD, a research assistant professor in the UNC School of Medicine, found that the protein Engrailed 1 is overexpressed in basal-like carcinomas, and she designed a chain of amino acids to shut down the protein and kill basal-like tumors in the lab.
Located in News / 2013 / November
Li, Wang named 2012 recipients of Jefferson-Pilot Award
Yun Li, PhD, Assistant Professor, Department of Genetics and the Department of Biostatistics, and Zefeng Wang, PhD, Assistant Professor, Department of Pharmacology, were selected to receive Jefferson-Pilot Awards this year.
Located in Vital Signs / 2012 / Sept. 27
UNC team discovers promising target for new pancreatic cancer treatments
In a paper published in the Journal of Biological Chemistry, a team from UNC Lineberger Comprehensive Cancer Center has narrowed the focus of this scientific quest to a protein called RGL2.
Located in News / 2010 / November
Grant to fund use of kinase test in HER2-positive breast cancer
Susan G. Komen for the Cure® has awarded a grant of almost $900,000 to Lisa A. Carey, MD, and Gary Johnson, PhD, to research clinical applications for the first broad-based test for protein kinase activation and response to inhibitory drugs in HER2-positive breast cancer.
Located in News / 2012 / May
UNC cardiologist named 2012 Judah Folkman Award recipient
Cam Patterson, MD, MBA, division chief of cardiology at the University of North Carolina at Chapel Hill School of Medicine, has been named the recipient of the 2012 North America Vascular Biology Association Judah Folkman Award in Vascular Biology.
Located in News / 2011 / October
Researchers shed pharmacological light on “dark” cellular receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Located in News / 2015 / November